Future of myeloma treatment

Ankit Kansagra, MD, UT Southwestern Medical Center, Dallas, TX, discusses future directions in the treatment and management of multiple myeloma including novel immunotherapies such as CAR-T and bispecific antibody products in this field, as well as where these therapies fit in the treatment landscape of multiple myeloma. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.